.After antibody-drug conjugate (ADC) professional Seagen was offered to Pfizer last year for a monst...
.On the heels of a period 3 gain that fell short to impress investors, Ironwood Pharmaceuticals is a...
.Do not cease Monte Rosa Therapies currently. The Boston-based biotech is having a ball after signin...
.Welcome to this week's Chutes & Ladders, our roundup of substantial leadership hirings, shooting...
.Celebrating his business's upsized initial public offering (IPO), Septerna chief executive officer ...
.AbbVie has gone back to the resource of its antipsychotic giant Vraylar trying to find another hit,...
.GenSight Biologics is actually weeks far from lacking money. Again. The biotech simply possesses en...
.Monopar Rehabs is recouping a drug coming from the scrap heap of AstraZeneca's uncommon disease pip...
.Along with brand-new records out on Arcus Biosciences' speculative HIF-2a prevention, one team of p...
.After creating a gene treatment alliance along with Dyno Therapies in 2020, Roche is back for even ...